drugset / Trial / NCT02178722
Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study was to assess the safety, tolerability, and efficacy when combining MK-3475 and INCB024360 in participants with certain cancers. This study was conducted in 2 phases, Phase 1 and Phase 2.
Timeline
- Start
- 2014-07-17
- Primary completion
- 2018-11-26
- Completion
- 2020-11-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Epacadostat | Small molecule | 25 mg | — |
| Subject | Pembrolizumab | Monoclonal antibody | — | — |